PT1365762E - Processo para aumentar os níveis de leptina utilizando compostos do ácido nicotínico - Google Patents

Processo para aumentar os níveis de leptina utilizando compostos do ácido nicotínico Download PDF

Info

Publication number: PT1365762E
Authority: PT; Portugal
Prior art keywords: nicotinic acid; leptin levels; acid compounds; increasing leptin; increase
Prior art date: 2001-03-08

Application number

PT02721337T

Other languages

English (en)

Inventor

Elaine Jacobson

Myron K Jacobson

Hyuntae Kim

Original Assignee

Univ Kentucky Res Found

Univ Arizona

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-08

Filing date

2002-03-08

Publication date

2008-11-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23047813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1365762(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-03-08 Application filed by Univ Kentucky Res Found, Univ Arizona filed Critical Univ Kentucky Res Found

2008-11-27 Publication of PT1365762E publication Critical patent/PT1365762E/pt

Links

PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 title abstract 8
102000016267 Leptin Human genes 0.000 title abstract 3
108010092277 Leptin Proteins 0.000 title abstract 3
NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 title abstract 3
229940039781 leptin Drugs 0.000 title abstract 3
229960003512 nicotinic acid Drugs 0.000 abstract 4
235000001968 nicotinic acid Nutrition 0.000 abstract 4
239000011664 nicotinic acid Substances 0.000 abstract 4
206010052428 Wound Diseases 0.000 abstract 1
208000027418 Wounds and injury Diseases 0.000 abstract 1
-1 nicotinic acid ester Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PT02721337T 2001-03-08 2002-03-08 Processo para aumentar os níveis de leptina utilizando compostos do ácido nicotínico PT1365762E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US27434901P	2001-03-08	2001-03-08

Publications (1)

Publication Number	Publication Date
PT1365762E true PT1365762E (pt)	2008-11-27

Family

ID=23047813

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT02721337T PT1365762E (pt)	2001-03-08	2002-03-08	Processo para aumentar os níveis de leptina utilizando compostos do ácido nicotínico

Country Status (12)

Country	Link
US (2)	US6750234B2 (pt)
EP (1)	EP1365762B1 (pt)
JP (1)	JP5057353B2 (pt)
CN (1)	CN1265792C (pt)
AT (1)	ATE409037T1 (pt)
CA (1)	CA2437844C (pt)
DE (1)	DE60229041D1 (pt)
DK (1)	DK1365762T3 (pt)
ES (1)	ES2315358T3 (pt)
MX (1)	MXPA03008096A (pt)
PT (1)	PT1365762E (pt)
WO (1)	WO2002072092A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040037828A1 (en)	2002-07-09	2004-02-26	Bar-Ilan University	Methods and pharmaceutical compositions for healing wounds
AU8436401A (en)	2000-07-31	2002-02-13	Univ Bar Ilan	Methods and pharmaceutical compositions for healing wounds
WO2002072092A1 (en) *	2001-03-08	2002-09-19	University Of Kentucky	Method for increasing leptin levels using nicotinic acid compounds
BR0315942A (pt)	2002-11-27	2005-10-04	Dmi Biosciences Inc	Tratamento de doenças e condições mediadas pelo aumento de fosforilação
US7736636B2 (en) *	2003-02-12	2010-06-15	Shaker Mousa	Method for treating occlusive vascular diseases & wound healing
US7218948B2 (en)	2003-02-24	2007-05-15	Qualcomm Incorporated	Method of transmitting pilot tones in a multi-sector cell, including null pilot tones, for generating channel quality indicators
US9544860B2 (en)	2003-02-24	2017-01-10	Qualcomm Incorporated	Pilot signals for use in multi-sector cells
US8811348B2 (en)	2003-02-24	2014-08-19	Qualcomm Incorporated	Methods and apparatus for generating, communicating, and/or using information relating to self-noise
ATE529125T1 (de)	2003-08-07	2011-11-15	Healor Ltd	Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung
US8969291B2 (en)	2004-10-08	2015-03-03	Enzo Therapeutics, Inc.	Methods for decreasing leptin levels or activity for treating inflammation
US8503938B2 (en)	2004-10-14	2013-08-06	Qualcomm Incorporated	Methods and apparatus for determining, communicating and using information including loading factors which can be used for interference control purposes
BRPI0516493A (pt)	2004-10-14	2008-09-09	Qualcomm Flarion Tech	métodos e aparelho para determinar, comunicar e utilizar informações que podem ser usadas para fins de controle de interferência
JP2006253769A (ja) *	2005-03-08	2006-09-21	National Institute Of Advanced Industrial & Technology	情報処理システムおよび方法
HUE034582T2 (en) *	2005-06-24	2018-02-28	Arizona Board Of Regents Acting On Behalf Of The Univ Of Arizona	A method of treating hair growth disorders, such as female alopecia, and compositions for use therein
EP2452691A3 (en)	2005-08-29	2012-09-05	HealOr Ltd.	Methods and compositions for prevention of diabetic and aged skin
US20070066512A1 (en) *	2005-09-12	2007-03-22	Dominique Verhelle	Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
US8989084B2 (en)	2005-10-14	2015-03-24	Qualcomm Incorporated	Methods and apparatus for broadcasting loading information corresponding to neighboring base stations
US9191840B2 (en)	2005-10-14	2015-11-17	Qualcomm Incorporated	Methods and apparatus for determining, communicating and using information which can be used for interference control
US9119220B2 (en)	2005-12-22	2015-08-25	Qualcomm Incorporated	Methods and apparatus for communicating backlog related information
US9148795B2 (en)	2005-12-22	2015-09-29	Qualcomm Incorporated	Methods and apparatus for flexible reporting of control information
US7801589B2 (en)	2005-12-22	2010-09-21	Olympus Corporation	In-vivo examination method and in-vivo examination apparatus
US9473265B2 (en)	2005-12-22	2016-10-18	Qualcomm Incorporated	Methods and apparatus for communicating information utilizing a plurality of dictionaries
US9451491B2 (en)	2005-12-22	2016-09-20	Qualcomm Incorporated	Methods and apparatus relating to generating and transmitting initial and additional control information report sets in a wireless system
US9338767B2 (en)	2005-12-22	2016-05-10	Qualcomm Incorporated	Methods and apparatus of implementing and/or using a dedicated control channel
US9137072B2 (en)	2005-12-22	2015-09-15	Qualcomm Incorporated	Methods and apparatus for communicating control information
US8514771B2 (en)	2005-12-22	2013-08-20	Qualcomm Incorporated	Methods and apparatus for communicating and/or using transmission power information
US9125093B2 (en)	2005-12-22	2015-09-01	Qualcomm Incorporated	Methods and apparatus related to custom control channel reporting formats
US9125092B2 (en)	2005-12-22	2015-09-01	Qualcomm Incorporated	Methods and apparatus for reporting and/or using control information
US9572179B2 (en)	2005-12-22	2017-02-14	Qualcomm Incorporated	Methods and apparatus for communicating transmission backlog information
US8437251B2 (en)	2005-12-22	2013-05-07	Qualcomm Incorporated	Methods and apparatus for communicating transmission backlog information
US20070253449A1 (en)	2005-12-22	2007-11-01	Arnab Das	Methods and apparatus related to determining, communicating, and/or using delay information
US20070243882A1 (en)	2006-04-12	2007-10-18	Qualcomm Incorporated	Method and apparatus for locating a wireless local area network associated with a wireless wide area network
JP5051471B2 (ja) *	2006-08-31	2012-10-17	智板見	休止期脱毛症治療剤
AU2008219633B2 (en) *	2007-02-28	2011-05-26	Arizona Board Of Regents On Behalf Of The University Of Arizona	Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy
AU2011204425A1 (en)	2010-01-11	2012-08-02	Healor Ltd.	Method for treatment of inflammatory disease and disorder
JP7229772B2 (ja) *	2016-04-22	2023-02-28	ジェイシー（ウーシー）カンパニー，インコーポレーテッド	イソチオシアネート系化合物の使用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4505896A (en) *	1979-04-19	1985-03-19	Elorac, Ltd.	Method of treating acne vulgaris and composition
DE3110611A1 (de) *	1981-03-18	1982-10-07	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen	"mitogene der leukozyten und des entzuendungsgewebes:natuerliche leukopoetine zur selektiven anregung der teilung und differenzierung von leukozyten"
GB8330969D0 (en) *	1983-11-21	1983-12-29	Wellcome Found	Promoting healing
DE3570598D1 (en) *	1984-11-15	1989-07-06	Nitto Denko Corp	Composition for percutaneous administration
US4965252A (en) *	1988-06-28	1990-10-23	Hauser-Kuhrts, Inc.	Cholesterol-lowering combination compositions of guar gum and niacin
EP0573568B1 (en) *	1991-03-01	2001-01-24	University Of Florida Research Foundation, Inc.	Use of nicotinic analogs for treatment of degenerative diseases of the nervous system
US5240945A (en) *	1992-02-18	1993-08-31	Warshaw Thelma G	Method and compositions for treating acne
US5496827A (en) *	1994-07-15	1996-03-05	Patrick; Jay	Compositions for the transdermal delivery of nutrients
US5612382A (en) *	1994-07-15	1997-03-18	Frances B. Fike	Composition for percutaneous absorption of pharmaceutically active ingredients
WO1996029405A2 (en) *	1995-03-20	1996-09-26	Ligand Pharmaceuticals Incorporated	MODULATORS OF ob GENE AND SCREENING METHODS THEREFOR
JP4553166B2 (ja) *	1995-05-01	2010-09-29	スカリスタリミテッド	ニコチン酸エステルおよびそれを含む薬剤組成物
US20040102358A1 (en) *	1997-05-19	2004-05-27	Scivoletto Rosemarie	Composition for treating skin conditions
AU4672199A (en) *	1998-05-20	1999-12-06	Yale University	Modulation of angiogenesis and wound healing
NZ511708A (en) *	1998-12-01	2003-12-19	Univ Kentucky Res Found	A method for enhancing protective cellular responses to genotoxic stress in skin
IT1306141B1 (it) *	1999-05-17	2001-05-30	Giampiero Valletta	Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
US6326034B1 (en) *	1999-12-22	2001-12-04	Natural Compounds Ltd	Natural extracted and synthetic antioxidant compositions
WO2002072092A1 (en) *	2001-03-08	2002-09-19	University Of Kentucky	Method for increasing leptin levels using nicotinic acid compounds

2002
- 2002-03-08 WO PCT/US2002/007256 patent/WO2002072092A1/en not_active Ceased
- 2002-03-08 MX MXPA03008096A patent/MXPA03008096A/es active IP Right Grant
- 2002-03-08 DE DE60229041T patent/DE60229041D1/de not_active Expired - Lifetime
- 2002-03-08 PT PT02721337T patent/PT1365762E/pt unknown
- 2002-03-08 JP JP2002571051A patent/JP5057353B2/ja not_active Expired - Fee Related
- 2002-03-08 EP EP02721337A patent/EP1365762B1/en not_active Expired - Lifetime
- 2002-03-08 AT AT02721337T patent/ATE409037T1/de active
- 2002-03-08 CN CNB028061209A patent/CN1265792C/zh not_active Expired - Fee Related
- 2002-03-08 US US10/094,063 patent/US6750234B2/en not_active Expired - Lifetime
- 2002-03-08 DK DK02721337T patent/DK1365762T3/da active
- 2002-03-08 ES ES02721337T patent/ES2315358T3/es not_active Expired - Lifetime
- 2002-03-08 CA CA002437844A patent/CA2437844C/en not_active Expired - Lifetime
2004
- 2004-04-14 US US10/825,405 patent/US20040198776A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2437844A1 (en)	2002-09-19
US20020128298A1 (en)	2002-09-12
US20040198776A1 (en)	2004-10-07
HK1065941A1 (en)	2005-03-11
ATE409037T1 (de)	2008-10-15
MXPA03008096A (es)	2005-10-05
ES2315358T3 (es)	2009-04-01
CN1265792C (zh)	2006-07-26
WO2002072092A1 (en)	2002-09-19
DE60229041D1 (de)	2008-11-06
EP1365762B1 (en)	2008-09-24
US6750234B2 (en)	2004-06-15
CN1496260A (zh)	2004-05-12
JP2004519488A (ja)	2004-07-02
CA2437844C (en)	2007-05-15
EP1365762A1 (en)	2003-12-03
EP1365762A4 (en)	2005-05-25
DK1365762T3 (da)	2008-11-17
JP5057353B2 (ja)	2012-10-24

Publication	Publication Date	Title
PT1365762E (pt)	2008-11-27	Processo para aumentar os níveis de leptina utilizando compostos do ácido nicotínico
WO2003032914A3 (en)	2003-11-20	Methods for treating substance abuse with cholinesterase inhibitors
WO2001081312A3 (en)	2002-08-08	Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
MY134841A (en)	2007-12-31	Substituted pyridines as selective cyclooxygenase-2 inhibitors
MXPA04005790A (es)	2004-09-13	Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona.
PL347469A1 (en)	2002-04-08	Use of certain drugs for treating nerve root injury
AU3831301A (en)	2001-08-27	Method for treating ocular pain
WO2004043456A8 (en)	2004-07-22	Cholesterol absorption inhibitors for the treatment of demyelination
WO2001049275A3 (en)	2001-12-13	Methods and compositions for mitigating pain using nitrate esters
TW200503668A (en)	2005-02-01	Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
NO20054476D0 (no)	2005-09-27	Forbindelser for behandling av smerte
AU2009246603A8 (en)	2015-08-13	Von willebrand factor (vwf) inhibitors for treatment or prevention of infarction
IL162384A0 (en)	2005-11-20	Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
WO2002039994A3 (en)	2003-08-21	Methods for the treatment and prevention of urinary stone disease
WO2001087343A3 (en)	2002-09-26	Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
DE60230155D1 (de)	2009-01-15	Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
AP2001002248A0 (en)	2001-09-30	Method for treating COPD.
NZ519722A (en)	2004-12-24	Treatment of diabetic ulcers
WO2005082375A3 (en)	2005-10-13	Treatment of interstitial cystitis with vitamin d compounds
WO2003053352A3 (en)	2003-11-20	Therapeutic compounds for treating dyslipidemic conditions
IL156140A0 (en)	2003-12-23	Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
WO2003024189A3 (en)	2003-05-08	Method of modulating sodium ion absorption in epithelial cells
MY148565A (en)	2013-04-30	Agent for therapy and/or improvement of disseminated intravascular coagulation
TW200600084A (en)	2006-01-01	Anti-coronavirus compounds
WO2008016665A3 (en)	2008-04-17	Imidazoacridine compounds for treating flt3 -mediated disorders